European Medicines Agency supportive of PAREA

At a recent meeting of EMA’s Chief Medical Officer Steffen Thirstrup, PAREA asked the agency to take a lead on bringing various EU institutions, agencies, scientists, and civil society together, similarly to what was done in the US earlier this year by the Federal National Institutes and National Academies. To that end, EMA could co-organize a European workshop with the US FDA and European stakeholders to discuss the future of psychedelic-assisted therapies in Europe.

Previous
Previous

Tadeusz Hawrot meets with various policymakers in Brussels

Next
Next

Meeting with the European Commission’s DG SANTE